Regeneron Pharmaceuticals, Inc.
(NASDAQ : REGN)

( )
REGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.08%61.590.0%$953.82m
GILDGilead Sciences, Inc. -1.14%76.061.0%$768.72m
AMGNAmgen, Inc. 8.17%255.121.3%$748.85m
REGNRegeneron Pharmaceuticals, Inc. -2.32%609.172.5%$678.56m
NVAXNovavax, Inc. -4.38%79.70102.0%$606.94m
BIIBBiogen, Inc. -1.04%264.771.6%$543.38m
VRTXVertex Pharmaceuticals, Inc. -1.39%286.281.9%$524.18m
ILMNIllumina, Inc. -0.49%368.553.5%$308.59m
ALXNAlexion Pharmaceuticals, Inc. 0.13%112.392.0%$229.11m
BMRNBioMarin Pharmaceutical, Inc. 2.03%125.844.3%$214.73m
SGENSeattle Genetics, Inc. -1.41%167.526.1%$201.85m
SRNESorrento Therapeutics, Inc. 10.35%6.931.8%$186.93m
SRPTSarepta Therapeutics, Inc. 3.33%165.6813.9%$168.66m
INCYIncyte Corp. -1.27%102.652.5%$160.00m
IMMUImmunomedics, Inc. 4.15%36.9111.0%$154.32m

Company Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.